TTK Healthcare Limited (NSE:TTKHLTCARE)
954.00
+26.45 (2.85%)
Nov 11, 2026, 3:00 PM IST
TTK Healthcare Revenue
TTK Healthcare had revenue of 2.33B INR in the quarter ending September 30, 2026, with 14.65% growth. This brings the company's total for the last twelve months to 9.18B, up 11.29% year-over-year. In the fiscal year ending March 31, 2026, TTK Healthcare had annual revenue of 8.57B with 6.96% growth.
Revenue (ttm)
9.18B
Revenue Growth
+11.29%
P/S Ratio
1.46
Revenue / Employee
6.63M
Employees
1,384
Market Cap
13.55B
Revenue by Segment
Fiscal year ended Mar 31, 2026 See the full TTK Healthcare breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 8.57B | 557.88M | 6.96% |
| Mar 31, 2025 | 8.01B | 487.00M | 6.47% |
| Mar 31, 2024 | 7.53B | 276.84M | 3.82% |
| Mar 31, 2023 | 7.25B | 1.26B | 21.01% |
| Mar 31, 2022 | 5.99B | 1.23B | 25.88% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Marksans Pharma | 33.92B |
| Pfizer | 26.54B |
| Rubicon Research | 21.00B |
| CORONA Remedies | 15.59B |
| Sanofi Consumer Healthcare India | 9.79B |
| SMS Pharmaceuticals | 9.74B |
| Senores Pharmaceuticals | 7.19B |
| Sai Parenteral's | 6.74B |
TTK Healthcare News
- 3 months ago - Wipro Consumer Care buys TTK’s Good Home, Eva brands for Rs 256 cr - The Times of India